Your browser is no longer supported. Please, upgrade your browser.
Settings
ARRY Array BioPharma Inc. daily Stock Chart
ARRY [NASD]
Array BioPharma Inc.
Index- P/E- EPS (ttm)-0.01 Insider Own0.20% Shs Outstand142.17M Perf Week-5.39%
Market Cap799.00M Forward P/E- EPS next Y-0.45 Insider Trans- Shs Float140.27M Perf Month-2.77%
Income9.40M PEG- EPS next Q-0.18 Inst Own86.10% Short Float18.99% Perf Quarter-27.30%
Sales51.90M P/S15.39 EPS this Y110.10% Inst Trans-1.94% Short Ratio15.77 Perf Half Y-30.01%
Book/sh0.30 P/B18.73 EPS next Y21.10% ROA5.30% Target Price11.08 Perf Year54.82%
Cash/sh1.25 P/C4.48 EPS next 5Y10.00% ROE90.80% 52W Range2.98 - 8.59 Perf YTD18.82%
Dividend- P/FCF- EPS past 5Y15.40% ROI2.20% 52W High-34.58% Beta1.61
Dividend %- Quick Ratio4.50 Sales past 5Y-0.80% Gross Margin14.50% 52W Low88.59% ATR0.29
Employees156 Current Ratio4.50 Sales Q/Q105.00% Oper. Margin6.40% RSI (14)44.90 Volatility4.77% 4.97%
OptionableYes Debt/Eq2.51 EPS Q/Q59.10% Profit Margin18.10% Rel Volume0.96 Prev Close5.77
ShortableYes LT Debt/Eq2.51 EarningsAug 03 BMO Payout0.00% Avg Volume1.69M Price5.62
Recom1.40 SMA20-1.39% SMA50-9.74% SMA200-14.46% Volume1,630,312 Change-2.60%
Jan-26-15Reiterated Stifel Buy $6 → $9
Aug-09-13Reiterated Stifel Buy $7 → $8
Jul-23-10Upgrade UBS Neutral → Buy $4.25
Apr-22-10Downgrade UBS Buy → Neutral
Nov-05-09Upgrade UBS Neutral → Buy
Sep-08-09Downgrade UBS Buy → Neutral
Sep-04-09Downgrade Robert W. Baird Outperform → Neutral $10 → $3
Sep-04-09Downgrade Leerink Swann Outperform → Mkt Perform $6 → $2
Sep-04-09Downgrade Boenning & Scattergood Outperform → Neutral
Jun-17-09Initiated Boenning & Scattergood Outperform $6
May-07-08Reiterated Rodman & Renshaw Mkt Outperform $18 → $15
Feb-07-08Initiated William Blair Outperform
Dec-20-07Reiterated Collins Stewart Buy $17 → $16
Dec-04-07Initiated Morgan Joseph Buy $16
Nov-07-07Reiterated Collins Stewart Buy $20 → $17
Oct-09-07Initiated Lehman Brothers Overweight $16
Aug-13-07Initiated Rodman & Renshaw Mkt Outperform $18
May-23-07Initiated JP Morgan Overweight
Jan-04-07Reiterated Piper Jaffray Outperform $14 → $20
Sep-02-15 05:54PM  Array BioPharma To Present At The Wells Fargo Securities Healthcare Conference PR Newswire +5.12%
Sep-01-15 01:04PM  ARRAY BIOPHARMA INC Financials
Aug-26-15 12:50PM  Redmile Group Fortifies Position In Array Biopharma Inc (ARRY); Broadwood Capital Boosts Stake In STAAR Surgical Company (STAA) at Insider Monkey
Aug-24-15 06:02AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
Aug-23-15 08:09PM  10-K for Array BioPharma, Inc. at Company Spotlight
Aug-21-15 05:18PM  ARRAY BIOPHARMA INC Files SEC form 10-K, Annual Report
07:39AM  3 Low-Price Biotech Stocks That Could Pop or Drop in 2016 at Motley Fool
Aug-19-15 09:17AM  5 Stocks Insiders Love Right Now at TheStreet
Aug-15-15 09:15AM  Key Insider Buying in Twitter, Level 3, Sears, MBIA and More at 24/7 Wall St.
Aug-14-15 09:59AM  Redmile Group Is Putting More Money Into Array BioPharma Inc. (ARRY) at Insider Monkey
Aug-12-15 04:12AM  Bulls come back to Array BioPharma
Aug-11-15 12:32PM  Notable option activity in equities
Aug-04-15 06:35PM  Cramer: Rare biotechs that stumped me at CNBC
06:03AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib
Aug-03-15 12:28PM  Edited Transcript of ARRY earnings conference call or presentation 3-Aug-15 1:00pm GMT
09:00AM  Array Biopharma Inc Earnings Call scheduled for 9:00 am ET today
08:18AM  Array BioPharma reports 4Q loss
08:00AM  Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 PR Newswire
07:07AM  Q4 2015 Array Biopharma Inc Earnings Release - Before Market Open
Jul-27-15 01:49PM  Array BioPharma To Report Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 On August 3, 2015 PR Newswire
Jul-22-15 06:03AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
02:01AM  AstraZeneca Provides Update On Selumetinib In Uveal Melanoma PR Newswire
Jul-06-15 05:13PM  Array BioPharma To Present At The Cantor Fitzgerald 2015 Healthcare Conference PR Newswire
08:02AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
08:00AM  Encorafenib-Based Regimens Show Promising Clinical Activity In BRAF-Mutant Colorectal Cancer Patients PR Newswire
Jun-10-15 03:04PM  One Of Mark Lamperts Small-Cap Biotech Picks Has Returned 84% This Year And Its Not Done Yet at Insider Monkey
Jun-04-15 09:40AM  Redmile Group returns an estimated 9.3% in May
Jun-02-15 08:01AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Entry into a Material Definitive Agreement
Jun-01-15 03:30PM  ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
09:00AM  Binimetinib And Encorafenib Combination Shows Promising Clinical Activity And Potential Differentiated Safety In BRAF-Mutant Melanoma PR Newswire
05:47AM  Put sale sees Array holding gains
May-28-15 09:00AM  Array BioPharma Announces Clinical Data Presentations At The 2015 ASCO Annual Meeting PR Newswire
May-26-15 09:00AM  Array BioPharma To Present At The Jefferies 2015 Global Healthcare Conference PR Newswire
May-10-15 08:11PM  10-Q for Array BioPharma, Inc. at Company Spotlight
May-09-15 09:45AM  4 Speculative Biotechs With Huge Analyst Targets at 24/7 Wall St.
May-07-15 09:00AM  Array BioPharma To Present At The Bank Of America Merrill Lynch Healthcare Conference And The UBS Global Healthcare Conference PR Newswire
06:09AM  ARRAY BIOPHARMA INC Files SEC form 10-Q, Quarterly Report
May-06-15 02:20PM  Is Isis just what the doctor ordered? +8.07%
May-05-15 09:25AM  Array BioPharma (ARRY) Looks Good: Stock Rises 13.1% - Tale of the Tape -8.11%
May-04-15 03:59PM  ARRAY BIOPHARMA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib +13.13%
11:00AM  What Is Really Driving Array Higher at 24/7 Wall St.
10:58AM  Array Biopharma (ARRY) Stock Jumping After Earnings Beat at TheStreet
09:00AM  Array Biopharma Inc Earnings Call scheduled for 9:00 am ET today
07:18AM  Array BioPharma beats Street 3Q forecasts
07:07AM  Q3 2015 Array Biopharma Inc Earnings Release - Before Market Open
07:00AM  Array BioPharma Reports Financial Results For The Third Quarter Of Fiscal 2015 PR Newswire
Apr-27-15 05:31PM  Array BioPharma To Report Financial Results For The Third Quarter Of Fiscal 2015 On May 4, 2015 PR Newswire -6.40%
Apr-21-15 02:39PM  Biotech Investors: May 29th Could Be A Big Day
Mar-31-15 04:27PM  Array BioPharma CEO Sees Big Opportunities in the Future at TheStreet
01:50PM  Array BioPharma CEO: Novartis Deal a Massive Momentum Builder at TheStreet
Mar-30-15 05:08PM  The latest drugs being tested to fight melanoma
Mar-03-15 08:25AM  4 Biotechs Expected to See Huge Buying on PowerShares Rebalance at 24/7 Wall St.
Mar-02-15 08:10AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Definit
08:00AM  Array Announces Completion Of Binimetinib And Encorafenib Transactions PR Newswire
Feb-26-15 11:02AM  Array BioPharma draws bullish bet
Feb-25-15 09:00AM  Array BioPharma To Present At The Cowen and Company Annual Healthcare Conference PR Newswire
Feb-18-15 02:26PM  How To Approach Momentum Trading Like A Pro at Investopedia
Feb-13-15 05:03PM  ARRAY BIOPHARMA INC Files SEC form 8-K, Entry into a Material Definitive Agreement
Feb-10-15 03:59PM  Oncolytics Seeks Orphan Drug Status for Reolysin in the U.S. - Analyst Blog
Feb-07-15 07:07PM  10-Q for Array BioPharma, Inc. at Company Spotlight
Feb-05-15 12:30PM  Array BioPharma To Present At The Leerink Swann Global Healthcare Conference PR Newswire
Feb-04-15 05:31PM  ARRAY BIOPHARMA INC Files SEC form 10-Q, Quarterly Report EDGAR Online
Feb-03-15 03:08PM  CFO Moves: Visa, Array BioPharma, Epizyme at The Wall Street Journal
09:28AM  Array BioPharma reports 2Q loss AP
09:00AM  Array Biopharma Inc Earnings Call scheduled for 9:00 am ET today CCBN
08:05AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Results of Operations and Financial Condition, Change in Directors or Princip EDGAR Online
08:00AM  Array Biopharma Reports Financial Results For The Second Quarter Of Fiscal 2015 PR Newswire
07:07AM  Q2 2015 Array Biopharma Inc Earnings Release - Before Market Open CCBN
Jan-27-15 08:51AM  Array BioPharma (ARRY) Jumps: Stock Adds 9.8% in Session - Tale of the Tape Zacks
Jan-26-15 03:00PM  Array BioPharma To Report Financial Results For The Second Quarter Of Fiscal 2015 On February 3, 2015 PR Newswire +9.85%
Jan-23-15 06:00PM  Array BioPharma shares jump on news of Novartis cancer-drug deal at American City Business Journals +40.79%
04:35PM  Equities end the day mixed... Yahoo Finance Contributors
12:02PM  Array shares jump after drugmaker details Novartis deal AP
11:52AM  Why Shares Of Array Biopharma Are Surging More Than 35% Benzinga
08:16AM  ARRAY BIOPHARMA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits EDGAR Online
08:00AM  Array Announces Agreement To Acquire ENCORAFENIB (LGX818) PR Newswire
Jan-21-15 08:42AM  Why You Shouldn't Bet Against Array BioPharma (ARRY) Stock - Tale of the Tape Zacks
Jan-08-15 02:00PM  Array BioPharma To Present At The Annual J.P. Morgan Healthcare Conference PR Newswire
Dec-31-14 08:59AM  19 Lesser-Known Biotech Stocks With Robust Drug Pipelines Benzinga
Dec-12-14 05:15PM  ARRAY BIOPHARMA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Definit EDGAR Online
Dec-11-14 08:15AM  The Zacks Analyst Blog Highlights: Cubist Pharmaceuticals, bluebird bio, Amgen, Incyte and Array Zacks
Dec-05-14 08:44AM  Array BioPharma (ARRY) Shares March Higher, Can It Continue? Zacks +10.29%
07:03AM  Array BioPharma, Inc. (ARRY) in Focus: Stock Soars 14.3% Zacks
Dec-04-14 02:00PM  Array BioPharma Regains Binimetinib Rights from Novartis Zacks +14.32%
12:39PM  Mid-Day Market Update: Hawaiian Electric Climbs On Merger News; Barnes & Noble Shares Slide Benzinga
10:35AM  Array BioPharma: When Losing a Partnership Is Good News at 24/7 Wall St.
10:34AM  Story Stocks from Briefing.com Briefing.com
Dec-03-14 04:06PM  ARRAY BIOPHARMA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Definit EDGAR Online
04:01PM  Array To Regain Worldwide Rights To Binimetinib PR Newswire
04:01PM  Array Biopharma Regains Rights to Cancer Drug From Novartis at TheStreet
Nov-25-14 02:00PM  Array BioPharma To Present At The Piper Jaffray And Oppenheimer 2014 Healthcare Conferences PR Newswire
Nov-24-14 10:00AM  Array BioPharma (ARRY) Is Today's Strong On High Volume Stock at TheStreet
Nov-10-14 10:00AM  Array BioPharma To Present At The Stifel 2014 Healthcare And Jefferies 2014 Global Healthcare Conferences PR Newswire
Nov-07-14 07:08PM  10-Q for Array BioPharma, Inc. Company Spotlight
Nov-05-14 04:18PM  ARRAY BIOPHARMA INC Files SEC form 10-Q, Quarterly Report EDGAR Online
Nov-04-14 04:49PM  ARRAY BIOPHARMA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Submission of Matters to a Vote o EDGAR Online
09:09AM  Array BioPharma meets 1Q profit forecasts AP
09:00AM  Array Biopharma Inc Earnings Call scheduled for 9:00 am ET today CCBN
08:00AM  Array BioPharma Reports Financial Results For The First Quarter Of Fiscal 2015 PR Newswire
07:07AM  Q1 2015 Array Biopharma Inc Earnings Release - Before Market Open CCBN
Array BioPharma Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drugs to treat patients with cancer in North America, Europe, and the Asia Pacific. The company's drugs in Phase III clinical trials include Binimetinib and Encorafenib for the treatment of cancer. Its drug candidates in Phase II clinical trials include Filanesib, a kinesin spindle protein inhibitor for multiple myeloma; ARRY-797, a p38 inhibitor for Lamin A/C-related dilated cardiomyopathy; ASC08/Danoprevir, a protease inhibitor for Hepatitis C virus; ASLAN001/ARRY-543, a pan-HER inhibitor for gastric or breast cancer; Ipatasertib/GDC-0068, an AKT inhibitor for cancer; Motolimod/VTX-2337, a toll-like receptor for cancer; and LY2606368, a chk-1 inhibitor for cancer. The company's Phase Ib drug candidate comprises GDC-0575, a chk-1 inhibitor for cancer; and ONT-380/ARRY-380, a HER2 inhibitor for breast cancer, as well as Phase I drug candidate includes GDC-0994, an ERK inhibitor for cancer and LOXO-101, a PanTrk inhibitor for cancer. Array BioPharma Inc. has collaboration agreements with Biogen Idec MA Inc.; Array and Celgene Corporation and Celgene Alpine Investment Co., LLC; Genentech, Inc.; Loxo Oncology, Inc.; Novartis International Pharmaceutical Ltd.; and Oncothyreon Inc. The company was founded in 1998 and is headquartered in Boulder, Colorado.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Redmile Group, LLC10% OwnerAug 26Buy5.4849,900273,45217,250,510Aug 28 05:29 PM
Redmile Group, LLC10% OwnerAug 25Buy5.45220,0001,199,00017,200,610Aug 25 07:16 PM
Redmile Group, LLC10% OwnerAug 24Buy5.32410,0002,181,20016,980,610Aug 25 07:16 PM
Redmile Group, LLC10% OwnerAug 21Buy5.45160,000872,00016,570,610Aug 25 07:16 PM
Redmile Group, LLC10% OwnerAug 12Buy5.93205,0001,215,65016,410,610Aug 13 07:16 PM
Redmile Group, LLC10% OwnerAug 11Buy5.85327,5001,915,87516,205,610Aug 13 07:16 PM
Redmile Group, LLC10% OwnerAug 10Buy5.81180,0001,045,80015,878,110Aug 10 08:59 PM
Redmile Group, LLC10% OwnerAug 07Buy5.67276,5431,567,99915,698,110Aug 10 08:59 PM
Redmile Group, LLC10% OwnerAug 06Buy5.85592,4503,465,83315,421,567Aug 10 08:59 PM
LEFKOFF KYLEDirectorMar 03Option Exercise2.8070,000196,05073,585Mar 04 08:50 PM
LEFKOFF KYLEDirectorMar 03Sale8.0070,000560,0703,585Mar 04 08:50 PM
Squarer RonCEOMar 02Sale8.2540,000330,00012,927Mar 04 08:13 PM
Robbins Andrews RSVP, Commercial OperationsMar 02Sale8.2521,576178,0020Mar 04 08:16 PM
Robbins Andrews RSVP, Commercial OperationsMar 01Option Exercise7.9632,069255,26932,069Mar 04 08:16 PM
Sandor VictorChief Medical Officer.Mar 01Option Exercise7.9617,440138,82217,440Mar 04 08:16 PM
MOORE JOHN RVP, General CounselMar 01Option Exercise7.9622,906182,33222,906Mar 04 08:14 PM
Squarer RonCEOMar 01Option Exercise7.9677,881619,93377,881Mar 04 08:13 PM
SNITMAN DAVIDCOO and VP, Business Devel.Mar 01Option Exercise7.9611,45391,16611,453Mar 04 08:12 PM
Saccomano Nicholas ACSOMar 01Option Exercise7.9611,45391,16611,453Mar 04 08:13 PM